Workflow
Albemarle(ALB) - 2024 Q4 - Annual Report
ALBAlbemarle(ALB)2025-02-12 22:09

Acquisitions and Investments - Albemarle acquired the remaining 40% ownership of the Kemerton lithium hydroxide processing facility for approximately 380million,withthetransactioneffectiveretroactivelytoApril1,2022[60].TheacquisitionofGuangxiTianyuanNewEnergyMaterialsCo.,Ltd.wascompletedforapproximately380 million, with the transaction effective retroactively to April 1, 2022[60]. - The acquisition of Guangxi Tianyuan New Energy Materials Co., Ltd. was completed for approximately 200 million, with a lithium processing plant capable of producing up to 25,000 metric tons of lithium carbonate equivalent annually[61]. - The restructuring of the MARBL Lithium Joint Venture reduced Albemarle's ownership interest from 60% to 50% as of October 18, 2023, impacting future revenue recognition from this joint venture[548]. - The company completed the acquisition of Guangxi Tianyuan New Energy Materials Co., Ltd. for approximately 200millionincash,whichincludedadeferralofabout200 million in cash, which included a deferral of about 29 million[601]. - The fair value of the assets acquired in the Guangxi Tianyuan acquisition included property, plant, and equipment valued at 106.6millionandotherintangiblesvaluedat106.6 million and other intangibles valued at 16.3 million[602]. - The restructuring of the MARBL joint venture allowed the company to acquire 100% ownership of the Kemerton lithium hydroxide processing facility, with a cash payment of approximately 380million[626].FinancialPerformanceThecompanysnetsalesfortheyearendedDecember31,2024,were380 million[626]. Financial Performance - The company’s net sales for the year ended December 31, 2024, were 5,377.5 million, a decrease of 44.5% compared to 9,617.2millionin2023[538].Thegrossprofitfor2024was9,617.2 million in 2023[538]. - The gross profit for 2024 was 62.5 million, significantly down from 1,185.9millionin2023,indicatingagrossmargindecline[538].Thecompanyreportedanetlossof1,185.9 million in 2023, indicating a gross margin decline[538]. - The company reported a net loss of 1,135.5 million for 2024, compared to a net income of 1,670.5millionin2023,reflectingasubstantialdownturninprofitability[538].Comprehensivelossincomefor2024was1,670.5 million in 2023, reflecting a substantial downturn in profitability[538]. - Comprehensive loss income for 2024 was 1,348.9 million, contrasting with comprehensive income of 1,702.8millionin2023[541].Thecompanyreportedanetlossof1,702.8 million in 2023[541]. - The company reported a net loss of 1,179,449,000 for the year ended December 31, 2023, compared to a net income of 1,573,476,000in2022[545].Thecompanyreportedaccumulatedothercomprehensivelossof1,573,476,000 in 2022[545]. - The company reported accumulated other comprehensive loss of (742,062,000) as of December 31, 2024[545]. - For the year ended December 31, 2024, Albemarle Corporation reported a net loss of 1,135.5millioncomparedtoanetincomeof1,135.5 million compared to a net income of 1,670.5 million in 2023, representing a significant decline in profitability[547]. Cash Flow and Liquidity - Cash flows from operating activities for 2024 were 702.1million,downfrom702.1 million, down from 1,325.3 million in 2023, indicating a decrease of approximately 47%[547]. - The company’s cash and cash equivalents at the end of 2024 were 1,192.2million,anincreaseof1,192.2 million, an increase of 302.3 million from 889.9millionattheendof2023[547].Thecompanyissued2,300sharesofmandatoryconvertiblepreferredstockin2024,withastatedvalueof889.9 million at the end of 2023[547]. - The company issued 2,300 shares of mandatory convertible preferred stock in 2024, with a stated value of 1,000 each, totaling 2,235,105thousand[543].Thecompanyreceived2,235,105 thousand[543]. - The company received 2,236.8 million from the issuance of mandatory convertible preferred stock in 2024, which was a new financing activity not present in the previous year[547]. - The company repaid a net amount of 620.0millionofcommercialpapernotesduringtheyearendedDecember31,2024,usingproceedsfromtheissuanceofmandatoryconvertiblepreferredstock[658].DebtandLiabilitiesAsofDecember31,2024,Albemarlehadvariableinterestrateborrowingsof620.0 million of commercial paper notes during the year ended December 31, 2024, using proceeds from the issuance of mandatory convertible preferred stock[658]. Debt and Liabilities - As of December 31, 2024, Albemarle had variable interest rate borrowings of 27.5 million, representing 1% of total outstanding debt, with an average interest rate of 0.33%[514]. - Long-term debt decreased from 3,541,002thousandin2023to3,541,002 thousand in 2023 to 3,118,142 thousand in 2024, a decline of approximately 12.0%[543]. - The total long-term debt maturities for 2025 are projected at 398.5million,withsignificantamountsdueinsubsequentyears[647].Thenetpensionliabilitydecreasedto398.5 million, with significant amounts due in subsequent years[647]. - The net pension liability decreased to 7.674 billion in 2024 from 8.771billionin2023,reflectingareductionofapproximately12.58.771 billion in 2023, reflecting a reduction of approximately 12.5%[665]. - Total noncurrent liabilities increased from 769.100 million in 2023 to 819.204millionin2024[688].EnvironmentalandSustainabilityGoalsAlbemarleaimstoachievenetzerocarbonemissionsby2050,withatargettoreducescope1and2carbonintensityby35819.204 million in 2024[688]. Environmental and Sustainability Goals - Albemarle aims to achieve net-zero carbon emissions by 2050, with a target to reduce scope 1 and 2 carbon intensity by 35% by 2030 from a 2019 baseline[55]. - The company plans to reduce freshwater usage intensity by 25% by 2030 in areas of high water risk, such as Chile and Jordan[56]. - The company is committed to responsible management of natural resources and aims to maximize the recovery of extracted minerals while preserving local environments[58]. Research and Development - Research and development expenses increased slightly to 86.7 million in 2024 from 85.7millionin2023,showingcontinuedinvestmentininnovation[538].Researchanddevelopmentexpensesareprimarilypersonnelrelatedandareexpensedasincurred,supportingcontractresearchandcustommanufacturingbusinesses[571].InventoryandAssetsTotalassetsdecreasedfrom85.7 million in 2023, showing continued investment in innovation[538]. - Research and development expenses are primarily personnel-related and are expensed as incurred, supporting contract research and custom manufacturing businesses[571]. Inventory and Assets - Total assets decreased from 18,270,652 thousand in 2023 to 16,609,649thousandin2024,adeclineofapproximately9.116,609,649 thousand in 2024, a decline of approximately 9.1%[543]. - Current assets fell from 5,216,919 thousand in 2023 to 3,842,262thousandin2024,representingadecreaseofabout26.43,842,262 thousand in 2024, representing a decrease of about 26.4%[543]. - Inventories decreased from 2,161,287 thousand in 2023 to 1,502,531thousandin2024,areductionofabout30.51,502,531 thousand in 2024, a reduction of about 30.5%[543]. - Finished goods inventory decreased from 1,624.9 million in 2023 to 912.7millionin2024,areductionofapproximately44912.7 million in 2024, a reduction of approximately 44%[611]. - Total inventory value dropped from 2,161.3 million in 2023 to 1,502.5millionin2024,reflectingadeclineofabout301,502.5 million in 2024, reflecting a decline of about 30%[611]. Compliance and Legal Matters - The company finalized agreements to resolve matters with the DOJ and SEC in September 2023[696]. - A total of 218.5 million was paid in aggregate fines, disgorgement, and prejudgment interest to the DOJ and SEC[696]. - The resolution does not include a compliance monitorship, but the company has agreed to ongoing compliance reporting obligations[697]. - The conduct related to the resolution occurred prior to 2018[696]. - The company voluntarily self-reported potential violations of the U.S. Foreign Corrupt Practices Act[695].